MicroRNA-135b, a HSF1 target, promotes tumor invasion and metastasis by regulating RECK and EVI5 in hepatocellular carcinoma

Oncotarget

Volumn 6, Issue 4, 2015, Pages 2421-2433

  Li, Yan ^a   Xu, Dan ^a   Bao, Chunyang ^a   Zhang, Yuannv ^a   Chen, Di ^a   Zhao, Fangyu ^a   Ding, Jie ^b   Liang, Linhui ^b   Wang, Qifeng ^b   Liu, Li ^b   Li, Jinjun ^a   Yao, Ming ^a   Huang, Shenglin ^b   He, Xianghuo ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

EVI5; Hepatocellular carcinoma; HSF1; MicroRNA 135b; RECK

Indexed keywords

HEAT SHOCK TRANSCRIPTION FACTOR 1; MICRORNA; MICRORNA 135B; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; EVI5 PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HEAT SHOCK TRANSCRIPTION FACTOR; MIRN135 MICRORNA, HUMAN; NUCLEAR PROTEIN; RECK PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; COPY NUMBER VARIATION; ECOTROPIC VIRAL INTEGRATION SITE 5 GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER CELL LINE; LIVER CELL CARCINOMA; METASTASIS; MOUSE; NONHUMAN; REVERSION INDUCING CYSTEINE RICH PROTEIN WITH KAZAL MOTIFS GENE; TUMOR INVASION; UPREGULATION; CELL MOTION; CONFOCAL MICROSCOPY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HEP-G2 CELL LINE; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GPI-LINKED PROTEINS; HEK293 CELLS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MICROSCOPY, CONFOCAL; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 84923034660     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2965     Document Type: Article

References (37)

1. El-Serag HB and Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007; 132(7):2557-2576.
2. Hanahan D and Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-674.
3. Jia D, Wei L, Guo W, Zha R, Bao M, Chen Z, Zhao Y, Ge C, Zhao F, Chen T, Yao M, Li J, Wang H, Gu J and He X. Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma. Hepatology. 2011; 54(4):1227-1236.
4. Jia D, Jing Y, Zhang Z, Liu L, Ding J, Zhao F, Ge C, Wang Q, Chen T, Yao M, Li J, Gu J and He X. Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma. Cell research. 2013.
5. Jing Y, Jia D, Wong CM, Oi-Lin Ng I, Zhang Z, Liu L, Wang Q, Zhao F, Li J, Yao M, Wu X and He X. SERPINA5 inhibits tumor cell migration by modulating the fibronectin-integrin beta1 signaling pathway in hepatocellular carcinoma. Molecular oncology. 2013.
6. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M and Croce CM. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101(9):2999-3004.
7. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-297.
8. Friedman RC, Farh KK, Burge CB and Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome research. 2009; 19(1):92-105.
9. He L and Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nature Reviews Genetics. 2004; 5(7):522-531.
10. Calin GA and Croce CM. MicroRNA signatures in human cancers. Nature Reviews Cancer. 2006; 6(11):857-866.
11. Esquela-Kerscher A and Slack FJ. Oncomirs-microRNAs with a role in cancer. Nature reviews Cancer. 2006; 6(4):259-269.
12. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F and Croce CM. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America. 2002; 99(24):15524-15529.
13. Ding J, Huang S, Wu S, Zhao Y, Liang L, Yan M, Ge C, Yao J, Chen T, Wan D, Wang H, Gu J, Yao M, Li J, Tu H and He X. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nature cell biology. 2010; 12(4):390-399.
14. Clark JC, Thomas DM, Choong PF and Dass CR. RECK-a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer and Metastasis Reviews. 2007; 26(3-4):675-683.
15. Lim YS and Tang BL. The Evi5 family in cellular physiology and pathology. FEBS letters. 2013; 587(12):1703-1710.
16. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, Ignatieva EV, Ananko EA, Podkolodnaya OA, Kolpakov FA, Podkolodny NL and Kolchanov NA. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic acids research. 1998; 26(1):362-367.
17. Calderwood S. HSF1, a versatile factor in tumorogenesis. Current molecular medicine. 2012; 12(9):1102-1107.
18. Nagel R, le Sage C, Diosdado B, van der Waal M, Oude Vrielink JA, Bolijn A, Meijer GA and Agami R. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer research. 2008; 68(14):5795-5802.
19. Lin CW, Chang YL, Chang YC, Lin JC, Chen CC, Pan SH, Wu CT, Chen HY, Yang SC, Hong TM and Yang PC. MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nature communications. 2013; 4:1877.
20. Matsuyama H, Suzuki HI, Nishimori H, Noguchi M, Yao T, Komatsu N, Mano H, Sugimoto K and Miyazono K. miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. Blood. 2011; 118(26):6881-6892.
21. Zhang L, Sun ZJ, Bian Y and Kulkarni AB. MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma. Cancer letters. 2013; 331(2):230-238.
22. Valeri N, Braconi C, Gasparini P, Murgia C, Lampis A, Paulus-Hock V, Hart JR, Ueno L, Grivennikov SI, Lovat F, Paone A, Cascione L, Sumani KM, Veronese A, Fabbri M, Carasi S, et al. MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer. Cancer cell. 2014; 25(4):469-483.
23. Lau SH and Guan XY. Cytogenetic and molecular genetic alterations in hepatocellular carcinoma. Acta pharmacologica Sinica. 2005; 26(6):659-665.
24. Cho CY, Wang JH, Chang HC, Chang CK and Hung WC. Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells. Journal of cellular physiology. 2007; 213(1):65-69.
25. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB, Ide C, Horan TP, Arakawa T, Yoshida H, Nishikawa S, Itoh Y, et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell. 2001; 107(6):789-800.
26. Stenzinger A, von Winterfeld M, Rabien A, Warth A, Kamphues C, Dietel M, Weichert W, Klauschen F and Wittschieber D. Reversion-inducing cysteine-rich protein with Kazal motif (RECK) expression: an independent prognostic marker of survival in colorectal cancer. Human pathology. 2012; 43(8):1314-1321.
27. Tian QS and Li DC. Lentivirus-mediated reversion-inducing cysteine-rich protein with Kazal motifs gene transfer suppresses pancreatic cancer invasion in vitro. Saudi medical journal. 2010; 31(7):752-758.
28. Xu J, Wu S and Shi X. Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma. Journal of orthopaedic research: official publication of the Orthopaedic Research Society. 2010; 28(12):1621-1625.
29. Zhang Y, Cheng S, Zhang G, Ma W, Liu Y, Zhao R, Zhang Q and Pang D. Low expression of RECK indicates a shorter survival for patients with invasive breast cancer. Cancer science. 2012; 103(6):1084-1089.
30. Span PN, Sweep CG, Manders P, Beex LV, Leppert D and Lindberg RL. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma. Cancer. 2003; 97(11):2710-2715.
31. Sasahara RM, Takahashi C and Noda M. Involvement of the Sp1 site in ras-mediated downregulation of the RECK metastasis suppressor gene. Biochemical and biophysical research communications. 1999; 264(3):668-675.
32. Liu LT, Peng JP, Chang HC and Hung WC. RECK is a target of Epstein-Barr virus latent membrane protein 1. Oncogene. 2003; 22(51):8263-8270.
33. Liao X, Du Y, Morse HC, 3rd, Jenkins NA and Copeland NG. Proviral integrations at the Evi5 locus disrupt a novel 90 kDa protein with homology to the Tre2 oncogene and cell-cycle regulatory proteins. Oncogene. 1997; 14(9):1023-1029.
34. Roberts T, Chernova O and Cowell JK. NB4S, a member of the TBC1 domain family of genes, is truncated as a result of a constitutional t(1;10)(p22;q21) chromosome translocation in a patient with stage 4S neuroblastoma. Human molecular genetics. 1998; 7(7):1169-1178.
35. Vihervaara A and Sistonen L. HSF1 at a glance. Journal of cell science. 2014; 127(Pt 2):261-266.
36. Dai C, Santagata S, Tang Z, Shi J, Cao J, Kwon H, Bronson RT, Whitesell L and Lindquist S. Loss of tumor suppressor NF1 activates HSF1 to promote carcinogenesis. The Journal of clinical investigation. 2012; 122(10):3742-3754.
37. Mendillo ML, Santagata S, Koeva M, Bell GW, Hu R, Tamimi RM, Fraenkel E, Ince TA, Whitesell L and Lindquist S. HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers. Cell. 2012; 150(3):549-562.